AGP Corporation (TYO:9377)

Blueprint Medicines Revenue

In the fiscal year ending March 31, 2025, AGP Corporation had annual revenue of 14.44B JPY with 11.22% growth. AGP Corporation had revenue of 4.06B in the quarter ending March 31, 2025, with 9.91% growth.

• Revenue: 14.44B
• Revenue Growth: +11.22%
• P/S Ratio: 1.39
• Revenue / Employee: 19.52M
• Employees: 740
• Market Cap: 20.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	14.44B	1.46B	11.22%
Mar 31, 2024	12.99B	1.95B	17.64%
Mar 31, 2023	11.04B	658.00M	6.34%
Mar 31, 2022	10.38B	-23.00M	-0.22%
Mar 31, 2021	10.40B	-4.34B	-29.43%